Highland Capital Management Fund Advisors, L.P. Charles River Laboratories International, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$865 Million
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $390,972 - $504,304	-2,227 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $48,130 - $76,836	-405 Reduced 15.39%	2,227 $388,000
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $329,184 - $378,139	2,632 New	2,632 $349,000

Others Institutions Holding CRL

# of Institutions

708

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$1.05 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$868 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

4.08M
Shares

$695 Million
0.14% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$372 Million
0.02% of portfolio
Allspring Global Investments Holdings, LLC

1.81M
Shares

$308 Million
0.56% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.67B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account